Genetically-modified mammals and immune cells are provided which are
capable of producing or secreting detectably-labeled immunoglobulin
molecules as a result of genetic modifications of at least one
immunoglobulin gene in the genome thereof, such that a fusion
polynucleotide encoding a detectable protein or peptide and an
immunoglobulin component molecule is present.